Functional immune assay using interferon-gamma could predict infectious events in end-stage kidney disease
- 30 November 2019
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 502, 287-292
- https://doi.org/10.1016/j.cca.2019.11.018
Abstract
No abstract availableKeywords
Funding Information
- Centre Hospitalier Universitaire de Nice
This publication has 36 references indexed in Scilit:
- Premature aging of circulating T cells in patients with end-stage renal diseaseKidney International, 2011
- Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory MalignancyClinical Cancer Research, 2010
- Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expressionNephrology Dialysis Transplantation, 2009
- Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatmentJCI Insight, 2009
- Impaired Immune Responses and Antigen-Specific Memory CD4+ T Cells in Hemodialysis PatientsJournal of the American Society of Nephrology, 2008
- Naïve and central memory T-cell lymphopenia in end-stage renal diseaseKidney International, 2006
- Altered CD46-mediated T cell co-stimulation in haemodialysis patientsClinical and Experimental Immunology, 2005
- The Euro-Balance Trial: The effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membraneKidney International, 2004
- Impact of Dialysis Dose and Membrane on Infection-Related Hospitalization and DeathJournal of the American Society of Nephrology, 2003
- Molecular aspects of T – and B-cell function in uremiaKidney International, 2001